Bang, J, Lobach, IV, Lang, AE, Grossman, M, Knopman, DS, Miller, BL, Schneider, LS, Doody, RS, Lees, A, Gold, M, Morimoto, BH, Boxer, AL, Williams, D, Lafontaine, AL, Marras, C, Jog, M, Panisset, M, Lang, A, Parker, L, Stewart, AJ, Corvol, J-C, Azulay, J-P, Couratier, P, Mollenhauer, B, Lorenzl, S, Ludolph, A, Benecke, R, Hoglinger, G, Lipp, A, Reichmann, H, Woitalla, D, Chan, D, Zermansky, A, Burn, D, Gozes, I, Roberson, E, Honig, L, Zamrini, E, Pahwa, R, Bordelon, Y, Driver-Dunkley, E, Lessig, S, Lew, M, Womack, K, Boeve, B, Ferrara, J, Hillis, A, Kaufer, D, Kumar, R, Xie, T, Gunzler, S, Zesiewicz, T, Dayalu, P, Golbe, LI, Jankovic, J, McGinnis, S, Santiago, A, Tuite, P, Isaacson, S, Leegwater-Kim, J, Litvan, I, Golbe, LI, Koestler, M, Jack, CR, Deerlin, VV, Randolph, C, Whitaker, S & Hirman, J 2016, '
Predicting disease progression in progressive supranuclear palsy in multicenter clinical trials',
Parkinsonism and Related Disorders.
https://doi.org/10.1016/j.parkreldis.2016.04.014